Biomarker-Driven Therapies in Gastric Cancer Treatment
Modern gastric cancer treatment increasingly considers biomarkers for the selection of targeted therapies and immunotherapies. In addition to classical methods such as surgery, chemotherapy, and radiation, biomarker analysis enables individualized treatment for patients.